AstraZeneca Pharma India Limited announced at the board meeting held on May 30, 2023 that the company approved retirement of Mr. Rajesh Marwaha from the Office of Chief Financial Officer and Whole-time Director of the Company with effect from the closing of business hours on September 30, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6,074 INR | -1.44% | -5.70% | +10.03% |
May. 28 | Astrazeneca Pharma India's Net Profit Rises in Fiscal Q4 | MT |
May. 27 | AstraZeneca Pharma India Limited Announces Resignation of Ankush Nandra as Non-Executive Director | CI |
1st Jan change | Capi. | |
---|---|---|
+10.03% | 1.85B | |
+40.73% | 739B | |
+31.96% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+14.72% | 240B | |
+9.49% | 210B | |
-4.95% | 206B | |
+6.17% | 164B |
- Stock Market
- Equities
- ASTRAZEN Stock
- News AstraZeneca Pharma India Limited
- AstraZeneca Pharma India Limited Announces Retirement of Mr. Rajesh Marwaha from the Office of Whole-Time Director, Effective September 30, 2023